RK Capital Management LLC Sells 141,500 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

RK Capital Management LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 43.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 187,600 shares of the company’s stock after selling 141,500 shares during the quarter. RK Capital Management LLC owned approximately 0.10% of Option Care Health worth $6,095,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of OPCH. IHT Wealth Management LLC lifted its position in Option Care Health by 4.7% during the 3rd quarter. IHT Wealth Management LLC now owns 9,352 shares of the company’s stock worth $294,000 after buying an additional 419 shares in the last quarter. Fifth Third Bancorp raised its position in Option Care Health by 120.7% in the 2nd quarter. Fifth Third Bancorp now owns 852 shares of the company’s stock worth $28,000 after purchasing an additional 466 shares during the last quarter. Public Employees Retirement System of Ohio lifted its holdings in Option Care Health by 39.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,236 shares of the company’s stock worth $70,000 after buying an additional 629 shares in the last quarter. Advisors Asset Management Inc. raised its position in shares of Option Care Health by 121.4% during the first quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company’s stock worth $42,000 after acquiring an additional 733 shares during the last quarter. Finally, Creative Planning boosted its holdings in Option Care Health by 10.5% in the second quarter. Creative Planning now owns 8,417 shares of the company’s stock valued at $273,000 after acquiring an additional 801 shares during the last quarter. Institutional investors and hedge funds own 94.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on OPCH shares. Barrington Research cut their target price on shares of Option Care Health from $41.00 to $35.00 and set an “outperform” rating on the stock in a research report on Thursday, October 26th. JPMorgan Chase & Co. reduced their price objective on shares of Option Care Health from $46.00 to $44.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 18th.

Insiders Place Their Bets

In other news, Director Elizabeth D. Bierbower acquired 3,000 shares of Option Care Health stock in a transaction dated Monday, October 30th. The stock was bought at an average cost of $26.37 per share, with a total value of $79,110.00. Following the completion of the transaction, the director now directly owns 13,515 shares of the company’s stock, valued at $356,390.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.38% of the company’s stock.

Option Care Health Stock Up 0.5 %

Shares of NASDAQ:OPCH opened at $29.83 on Tuesday. The company has a 50 day moving average price of $31.28 and a two-hundred day moving average price of $31.55. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.39 and a current ratio of 1.79. The company has a market capitalization of $5.28 billion, a PE ratio of 21.06, a PEG ratio of 1.01 and a beta of 1.20. Option Care Health, Inc. has a 52 week low of $24.23 and a 52 week high of $35.74.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, October 25th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. Option Care Health had a return on equity of 18.22% and a net margin of 6.12%. The business had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.09 billion. Analysts forecast that Option Care Health, Inc. will post 1.43 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.